206 related articles for article (PubMed ID: 8259188)
1. Treatment of chronic hepatitis D with interferon alfa-2a.
Farci P; Mandas A; Coiana A; Lai ME; Desmet V; Van Eyken P; Gibo Y; Caruso L; Scaccabarozzi S; Criscuolo D
N Engl J Med; 1994 Jan; 330(2):88-94. PubMed ID: 8259188
[TBL] [Abstract][Full Text] [Related]
2. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
Poynard T; Bedossa P; Chevallier M; Mathurin P; Lemonnier C; Trepo C; Couzigou P; Payen JL; Sajus M; Costa JM
N Engl J Med; 1995 Jun; 332(22):1457-62. PubMed ID: 7739681
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.
Davis GL; Balart LA; Schiff ER; Lindsay K; Bodenheimer HC; Perrillo RP; Carey W; Jacobson IM; Payne J; Dienstag JL;
N Engl J Med; 1989 Nov; 321(22):1501-6. PubMed ID: 2509916
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.
Lai MY; Kao JH; Yang PM; Wang JT; Chen PJ; Chan KW; Chu JS; Chen DS
Gastroenterology; 1996 Nov; 111(5):1307-12. PubMed ID: 8898645
[TBL] [Abstract][Full Text] [Related]
6. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
[TBL] [Abstract][Full Text] [Related]
7. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
[TBL] [Abstract][Full Text] [Related]
8. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
Lindsay KL; Davis GL; Schiff ER; Bodenheimer HC; Balart LA; Dienstag JL; Perrillo RP; Tamburro CH; Goff JS; Everson GT; Silva M; Katkov WN; Goodman Z; Lau JY; Maertens G; Gogate J; Sanghvi B; Albrecht J
Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy Group.
Davis GL; Balart LA; Schiff ER; Lindsay K; Bodenheimer HC; Perrillo RP; Carey W; Jacobson IM; Payne J; Dienstag JL
J Hepatol; 1990; 11 Suppl 1():S31-5. PubMed ID: 2127785
[TBL] [Abstract][Full Text] [Related]
10. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.
Farci P; Roskams T; Chessa L; Peddis G; Mazzoleni AP; Scioscia R; Serra G; Lai ME; Loy M; Caruso L; Desmet V; Purcell RH; Balestrieri A
Gastroenterology; 2004 Jun; 126(7):1740-9. PubMed ID: 15188169
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response.
Madejón A; Cotonat T; Bartolomé J; Castillo I; Carreño V
Hepatology; 1994 Jun; 19(6):1331-6. PubMed ID: 8188163
[TBL] [Abstract][Full Text] [Related]
12. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group.
Lin R; Roach E; Zimmerman M; Strasser S; Farrell GC
J Hepatol; 1995 Nov; 23(5):487-96. PubMed ID: 8583134
[TBL] [Abstract][Full Text] [Related]
13. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.
Weltman MD; Brotodihardjo A; Crewe EB; Farrell GC; Bilous M; Grierson JM; Liddle C
J Viral Hepat; 1995; 2(1):39-45. PubMed ID: 7493293
[TBL] [Abstract][Full Text] [Related]
14. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
[TBL] [Abstract][Full Text] [Related]
16. Therapy of chronic delta hepatitis with interferon alfa-2b.
Di Bisceglie AM; Martin P; Lisker-Melman M; Kassianides C; Korenman J; Bergasa NV; Baker B; Hoofnagle JH
J Hepatol; 1990; 11 Suppl 1():S151-4. PubMed ID: 2079575
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis.
Yurdaydin C; Bozkaya H; Karaaslan H; Onder FO; Erkan OE; Yalçin K; Değertekin H; Bozdayi AM; Uzunalimoğlu O
J Viral Hepat; 2007 Nov; 14(11):812-6. PubMed ID: 17927618
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA.
Yokosuka O; Kato N; Hosoda K; Ito Y; Imazeki F; Ohto M; Omata M
Gut; 1995 Nov; 37(5):721-6. PubMed ID: 8549952
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of recombinant human alpha-interferon for chronic non-A, non-B hepatitis.
Kakumu S; Arao M; Yoshioka K; Ichimiya H; Murase K; Aoi T; Kusakabe A
Am J Gastroenterol; 1989 Jan; 84(1):40-5. PubMed ID: 2521421
[TBL] [Abstract][Full Text] [Related]
20. Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A,non-B viral hepatitis. A randomized controlled trial.
David E; Pucci A; Palladin D; Saracco G; Garello E; Pintus C; Rocca G; Chiandussi L; Solinas A; Mollo F
Am J Clin Pathol; 1992 Oct; 98(4):397-401. PubMed ID: 1415021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
